Leadership
Team

Esteban Corley, Director of mAbxience Argentina (pharmADN) has more than 30 years’ working experience with Biopharmaceuticals. All his career has been devoted to develop, manufacture and market Biosimilar pharmaceuticals to improve access and affordability.

During his professional career he has co-founded several Biotech companies in Argentina and contributed  to achieve close collaborations between them and European Biotech companies underlining the international scope of these biotech ventures.

Esteban has also worked for the Argentine Ministry of Science and Technology as the Director of an international cooperation program between the European Union and Mercosur countries

In 2007 Esteban co-founded pharmADN, a company that is an essential member of the mAbxience group, producing monoclonal antibodies.

He is a member of the advising committee for the CABBIO (Argentine-Brazilian Biotechnology center) and a member of the Board of Directors of Biotecsur, Mercosur´s Biotechnology Platform, he is also a member of the Argentine Chamber of Biotechnology.

Esteban holds a degree in Biological Sciences from the University of Buenos Aires, and a Business degree from the Universidad Austral.

Mauricio Seigelchifer is Technology Transfer Director in mAbxience. He has over 30 years’ experience working in the field of biopharmaceuticals. He is very committed to improving the access of all the patients to the biopharmaceutical medicines.

Mauricio is co-founder of several Biotech companies where he helped to develop and commercialize medicines as Interferon alfa, Interferon beta, Erythropoietin and a vaccine against Hepatitis B. For more than 12 years he was President of PC Gen.

In 2007 Mauricio co-founded pharmADN, a company that is an essential part of the mAbxience group. pharmADN was initially created as an R&D company which is now producing monoclonal antibodies.

Mauricio is Member of the Proteins Expert Committee of the USP (United States Pharmacopeia) 

Mauricio obtained a PhD in Biological Sciences at the Universidad de Buenos Aires, and later on, he performed a Post Doc at The Wistar Institute in Philadelphia.

Francisco Olivera is Director of the mAbxience plant in León. He has an extensive, 15-year track record in the pharmaceutical industry.

Francisco began his career at a biotechnology laboratory specialising in developing and manufacturing recombinant cytokines for therapeutic use. He worked in areas including cell culture, protein purification and analytical development.

In 2009, Francisco joined the team at PharmADN, and later mAbxience, where he was directly involved in the development of monoclonal antibodies. Francisco took over as head of operations, and played a key role in the design and installation of mAbxience's first production plant in Buenos Aires.

When mAbxience acquired Genhelix in July 2014, Francisco relocated to León, where he worked on the construction and commissioning of the new plant and held the role of Operations Manager for four years.

In 2018 and 2019 he was Commercial Manager for Latin America, participating directly in business development for biosimilar products throughout the region.
Francisco has a degree in Biotechnology from Argentina's National University of Quilmes and an MBA from UADE Business School in Buenos Aires.

Susana Millán is Medical Director in mAbxience. During more than 20 years she has acquired a broad expertise in the field of clinical studies, pharmacovigilance, data management, regulatory affairs, pharmacology and clinical strategy.

Susana started to work in the pharmaceutical industry in the field of new drug development in oncology from the early development in Rhone Poulenc Rorer (Sanofi Group), as Clinical Research Associate, to later become Oncology Manager, in charge of Gene Therapy Phase I Studies. She later spent 10 years in Pharmamar in the Clinical Development Department, where she took the position of International Global Director for Clinical Operations and Data Management, managing the goals and objectives of the clinical trials in Oncology and Hematology indications.

She joined mAbxience in 2011 as Medical Director, including Medical, Clinical Trials and Pharmacovigilance departments. She is in charge of managing the clinical development of the company’s pipeline, identifying opportunities and leading initiatives to streamline processes and enhance productivity, efficiency and quality of outputs for Clinical activities.

Susana holds a University degree in Life Sciences (Biology & Biochemistry) from Universidad Complutense de Madrid University. She has completed her PhD in Molecular Biology and postdoctoral studies in Human Physiology in the Medicine Faculty of Complutense de Madrid University.

Eduardo Cioppi is the Commercial Director for LATAM at mAbxience. He has over 25 years’ experience in the pharmaceutical industry in the areas of quality, regulatory affairs, business development and marketing.

Eduardo started his professional career in quality control at Novartis where he became the head of the analytical laboratory. He subsequently joined Abbott Laboratories Argentina as Quality Engineering Manager, where his main responsibility was the administration of the subsidiary’s central documentation system and quality assurance processes.

After years of experience in multinational companies, he joined Laboratorios Bagó as Quality Control Manager, where he was also responsible for organising the Regulatory Affairs Department. He subsequently ended up working in business development areas as Regional Manager of Asia, Africa and Europe. In this role, he acquired experience in commercial sectors and business development in various regions.

After 10 years at Bagó, he joined Amega Biotech, where he performed management roles on a global level in the areas of regulatory affairs, quality and business development. This is also where he started to work in the biotechnology business.

In 2016, he joined mAbxience as Commercial Director for LATAM. He is responsible for business development in the region, generating plans and projects for new commercial opportunities and administrating and managing existing mAbxience commercial operations in Latin America.

Eduardo has a degree in Chemical Sciences from the Universidad de Buenos Aires, has completed a master’s in Business Management from the Universidad Católica Argentina and has a postgraduate in Project Management from the Instituto Tecnológico de Buenos Aires (ITBA).